2020
DOI: 10.1016/j.ensci.2020.100249
|View full text |Cite
|
Sign up to set email alerts
|

Acute management of a stroke-like episode in MELAS syndrome: What should we know?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
7
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(8 citation statements)
references
References 6 publications
0
7
1
Order By: Relevance
“…We do not agree with the notion that the index patient is the first adult case with good clinical outcome after “quick implementation of this approach” [ 1 ]. Several adults receiving ASD in addition to NO-precursors have been reported which responded favourably under this regimen [ [4] , [5] , [6] ].…”
contrasting
confidence: 65%
See 1 more Smart Citation
“…We do not agree with the notion that the index patient is the first adult case with good clinical outcome after “quick implementation of this approach” [ 1 ]. Several adults receiving ASD in addition to NO-precursors have been reported which responded favourably under this regimen [ [4] , [5] , [6] ].…”
contrasting
confidence: 65%
“…With interest we read the article by González-Pinto González et al about the management of a first ever stroke-like episode (SLE), with a corresponding stroke-like lesion (SLL), which was hyperintense on fluid attenuation inversion recovery (FLAIR) and diffusion weighted imaging (DWI) but isointense on apparent diffusion coefficient (ADC) maps, in a 38 years old male, who was diagnosed with mitochondrial encephalopathy, lactic acidosis, and stroke-like episode (MELAS) syndrome at age 30 years upon the clinical presentation (hypoacusis, permanent hyper-creatine-kinase (CK)-emia), a positive family history for MELAS (maternal uncle), and the detection of the variant m.3243A > G [ 1 ]. The SLE occurred despite regular intake of l -carnitine, coenzyme-Q (CoQ), and L-arginine (21 g/d) starting at age 30 years [ 1 ].…”
mentioning
confidence: 99%
“…Several pathogeneses, including mitochondrial angiopathy, metabolic defects, and neuronal hyperexcitability, have been considered to have a potential role in this clinical condition. 2 The mechanism of mitochondrial angiopathy could be associated with ischemia due to small vessel injury; it is rarely involved in the large vessel for SE in MELAS. 3 However, some cases of large vessels involvement in MELAS are reported, including This is the first case report of endovascular revascularization therapy for ICA dissection in a patient with MELAS.…”
Section: Discussionmentioning
confidence: 99%
“…Patients are prescribed a mitochondrial "cocktail" of antioxidants and cofactors to enhance metabolism and reduce oxidative stress. Consensus guidelines now recommend the administration of high-dose intravenous L-arginine (a nitric oxide precursor) in patients with acute neurological symptoms consistent with stroke-like episodes (Gonz ález et al, 2020).…”
Section: Treatmentmentioning
confidence: 99%